Mesoblast Ltd - Company Profile
Powered by 
All the data and insights you need on Mesoblast Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Mesoblast Ltd Strategy Report
- Understand Mesoblast Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Mesoblast Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP3129468B1 | Grant | VERBESSERTE STAMMZELLENZUSAMMENSETZUNG | A61K35/28; A61P43/00; A61P7/02; A61P9/00; A61P9/10; C12N2500/38; C12N2501/135; C12N2501/2301; C12N2501/25; C12N2501/39; C12N5/0662; C12N5/0663 | September 21, 2022 |
| AU2021222342A1 | Application | Method for treating chronic graft versus host disease | A61K35/28; A61P37/06; C12N5/0663; C12N5/0669 | September 15, 2022 |
| US20220275337A1 | Application | CELLULAR COMPOSITIONS COMPRISING VIRAL VECTORS AND METHODS OF TREATMENT | A61K35/28; A61P35/00; C12N15/86; C12N5/0662 | September 01, 2022 |
| CA2816489C | Grant | PERIVASCULAR MESENCHYMAL PRECURSOR CELLS | A61K35/28; A61K35/44; A61K38/00; A61K9/0014; A61P9/00; A61P9/04; A61P9/10; C12N2500/42; C12N2501/11; C12N2501/135; C12N2501/165; C12N2501/235; C12N2501/39; C12N2506/1392; C12N5/0663; C12N5/0667; C12N5/0668; C12N5/0691 | August 23, 2022 |
| AU2022209219A1 | Application | Methods of treating or preventing respiratory conditions | A61K35/28; A61P11/00; A61P11/06; A61P37/08; C12N5/0663 | August 18, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer